Objective To observe the effects of Sanxue Mingmu Tablets (散血明目片) combined with conbercept on patients with wet age-related macular degeneration (wAMD).Methods A total of 70 patients with wAMD were randomly divided into a treatment group with 35 cases (51 eyes) and a control group with 35 cases (50 eyes). The control group was treated with intravitreal injection of conbercept 0.05 ml once a month for three times. The treatment group was additionally treated with oral Sanxue Mingmu Tablets 2.4 g each time, three times a day for three months...
